✦ LIBER ✦

Assessing the risks, benefits and costs of stroke prevention in AF

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statins in the secondary prevention of s

✍ Luis Castilla-Guerra; María del Carmen Fernández-Moreno; Jesús Alvarez-Suero 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Secondary Stroke Prevention in Atrial Fi

✍ Peter J. Koudstaal; Adriana Koudstaal 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 77 KB

A Benefit-Risk Assessment of Agents Used

✍ Dr Ronald S. MacWalter, Colin P. Shirley 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 255 KB

Rivaroxaban and recurrent stroke prevent

✍ Philip B Gorelick 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 47 KB

Benefits and risks of oral anticoagulati

✍ David A. Garcia 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Dual antiplatelet therapy in recurrent s

✍ Farooq, Muhammad U. (author);Gorelick, Philip B. (author) 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 325 KB